C. Parkin

Christopher G Parkin, Lawrence Blonde, L. Blonde, 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Use of an Automated Bolus Calculator Reduces Fear of Hypoglycemia and Improves Confidence in Dosage Accuracy in Patients with Type 1 Diabetes Mellitus Treated with Multiple Daily Insulin Injections

Mansoor Ashraf, K. Barnard, C. Parkin, 2012, Journal of diabetes science and technology.

Eating Disorders and Diabetes: Screening and Detection

D. Kendall, S. Crow, C. Parkin, 2009, Diabetes Spectrum.

Is There a Place for Insulin Pump Therapy in Your Practice

Jay S. Skyler, J. Skyler, D. Kruger, 2007 .

Use of Automated Bolus Advisors May Improve Adherence to Multiple Daily Insulin Injection Therapy

K. Barnard, C. Parkin, R. Wagner, 2012, Journal of Diabetes Science and Technology.

Use of Diabetes Data Management Software Reports by Health Care Providers, Patients With Diabetes, and Caregivers Improves Accuracy and Efficiency of Data Analysis and Interpretation Compared With Traditional Logbook Data

Christopher G. Parkin, D. Hinnen, C. Parkin, 2014, Journal of diabetes science and technology.

Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control – Continuous Glucose Monitoring is the Solution

C. Parkin, P. Adolfsson, D. Rentoul, 2018, European endocrinology.

Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

L. Billings, D. Price, C. Parkin, 2018, Diabetes technology & therapeutics.

Changes in A1C Levels Are Significantly Associated With Changes in Levels of the Cardiovascular Risk Biomarker hs-CRP

W. Polonsky, J. L. Bermejo, L. Fisher, 2013, Diabetes Care.

Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]

K. Barnard, D. Cavan, Bettina Petersen, 2012, BMC Family Practice.

9th Annual Symposium on Self-Monitoring of Blood Glucose, April 28-30, 2016, Madrid, Spain.

C. Parkin, R. Hinzmann, Anita Homberg, 2016, Diabetes technology & therapeutics.

The Impact of Structured Self-Monitoring of Blood Glucose Combined With Intensive Education on HbA1c Levels, Hospitalizations, and Quality-of-Life Parameters in Insulin-Treated Patients With Diabetes at Primary Care in Serbia: The Multicenter SPA-EDU Study

K. Lalić, A. Jotic, N. Lalic, 2017, Journal of diabetes science and technology.

Is Hyperglycemia a Causal Factor in Cardiovascular Disease?

J. Davidson, C. Parkin, 2009, Diabetes Care.

What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring

J. McGill, G. Umpierrez, D. Kruger, 2021, Diabetes Technology & Therapeutics.

Health-care disparities in the use of diabetes technologies in the UK

C. Parkin, Katherine Barnard-Kelly, 2023, International Journal of Diabetes and Technology.

Increase Access, Reduce Disparities: Recommendations for Modifying Medicaid CGM Coverage Eligibility Criteria.

J. McGill, G. Forlenza, G. Umpierrez, 2022, Journal of diabetes science and technology.

Past, Present, and Future of Continuous Glucose Monitors (CGMs).

C. Parkin, Satish K Garg, 2023, Diabetes technology & therapeutics.

Value of Self-Monitoring Blood Glucose Pattern Analysis in Improving Diabetes Outcomes

Christopher G Parkin, J. Davidson, C. Parkin, 2009, Journal of diabetes science and technology.

Self-monitoring of blood glucose: benefits and utilization.

Tommy Johnson, Christy L Parkin, Christopher G Parkin, 2006, The Diabetes educator.

Results that matter: structured vs. unstructured self-monitoring of blood glucose in type 2 diabetes.

D. Hinnen, C. Parkin, Ann Buskirk, 2012, Diabetes research and clinical practice.

Integrated Personalized Diabetes Management (PDM)

L. Heinemann, B. Kulzer, I. Vesper, 2016, Journal of diabetes science and technology.

Improving the Quality of Outpatient Diabetes Care Using an Information Management System

C. Parkin, D. Messinger, J. Weissmann, 2016, Journal of diabetes science and technology.

A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction.

R. Meek, C. Clark, C. Parkin, 2001, Diabetes care.

Rethinking the Viability and Utility of Inhaled Insulin in Clinical Practice

L. Heinemann, C. Parkin, 2018, Journal of diabetes research.

11th Annual Symposium on Self-Monitoring of Blood Glucose: April 12-14, 2018, Oslo, Norway.

C. Parkin, R. Hinzmann, Anita Homberg, 2018, Diabetes technology & therapeutics.

12th Roche Diabetes Care Network Meeting: April 11–13, 2019, Copenhagen, Denmark

C. Parkin, R. Hinzmann, Christine Zepezauer, 2020, Diabetes technology & therapeutics.

The Emerging Role of Telemedicine and Mobile Health Technologies in Improving Diabetes Care.

S. Garg, C. Parkin, 2019, Diabetes technology & therapeutics.

Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial

G. Grunberger, M. Matoulek, C. Parkin, 2020, Diabetes Care.

Putting medications where they belong: Practical advice for managing type 2 diabetes in clinical practice

D. Hinnen, C. Parkin, J. Unger, 2013, Journal of the American Association of Nurse Practitioners.

All Children Deserve to Be Safe, Mothers Too: Evidence and Rationale Supporting CGM Use in Gestational Diabetes Within the Medicaid Population.

C. Parkin, N. Argento, C. Levy, 2023, Journal of diabetes science and technology.

Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused

C. Parkin, Quang Nguyen, Anish Arul Iyyavoo, 2022, Journal of diabetes science and technology.

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion

J. McGill, G. Forlenza, G. Umpierrez, 2021, Diabetes technology & therapeutics.

Efficacy of the Omnipod Insulin Management System on Glycemic Control in Patients With Type 1 Diabetes Previously Treated With Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion

H. Zisser, J. Layne, C. Parkin, 2016, Journal of diabetes science and technology.

Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

C. de Beaufort, C. Cobelli, R. Hovorka, 2022, Endocrine reviews.

CGM—How Good Is Good Enough?

Michael Schoemaker, Christopher G. Parkin, C. Parkin, 2016 .

Use of Continuous Glucose Monitoring Can Address Patient Fears and Facilitate Improved Glycaemic Management

C. Parkin, J. Unger, 2010 .

Efficacy and safety of an oral device to reduce food intake and promote weight loss

J. Dixon, D. Ryan, C. Parkin, 2017, Obesity science & practice.

Use of Continuous Glucose Monitoring in Detecting Reactive Hypoglycemia in Individuals Without Diabetes

C. Parkin, Shalin Pandya, Kai Chin, 2018, Journal of diabetes science and technology.

Is Continuous Glucose Monitoring Underappreciated in the UK?

Melissa Holloway, C. Parkin, Melissa R. Holloway, 2017, European endocrinology.

The impact of structured blood glucose testing on attitudes toward self-management among poorly controlled, insulin-naïve patients with type 2 diabetes.

W. Polonsky, L. Fisher, Bettina Petersen, 2012, Diabetes research and clinical practice.

The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes: Design of the Structured Testing Program (STeP) Study, a cluster-randomised, clinical trial [NCT00674986]

W. Polonsky, L. Fisher, D. Hinnen, 2010, BMC family practice.

protocolThe value of episodic , intensive blood glucose monitoring in non-insulin treated persons with type 2 diabetes : Design of the Structured Testing Program ( STeP ) Study , a cluster-randomised , clinical trial [ NCT 00674986 ]

W. Polonsky, L. Fisher, D. Hinnen, 2015 .

Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trial.

K. Barnard, D. Cavan, Bettina Petersen, 2014, Diabetes Technology & Therapeutics.

Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study

Christopher G Parkin, Bettina Petersen, R. Ziegler, 2016, Pediatric diabetes.

Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct study*

A. Maran, D. Tschoepe, W. Fisher, 2014, Journal of clinical & translational endocrinology.

A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study.

Christopher G Parkin, W. Polonsky, L. Fisher, 2011, Diabetes technology & therapeutics.

10th Annual Symposium on Self-Monitoring of Blood Glucose, April 27–29, 2017, Warsaw, Poland

C. Parkin, R. Hinzmann, Anita Homberg, 2018, Diabetes technology & therapeutics.

Prospective, randomized trial on intensive SMBG management added value in non-insulin-treated T2DM patients (PRISMA): a study to determine the effect of a structured SMBG intervention

D. Cucinotta, M. Porta, A. Tiengo, 2011, Acta Diabetologica.

Recognition, Prevention, and Proactive Management of Hypoglycemia in Patients with Type 1 Diabetes Mellitus

C. Parkin, J. Unger, 2011, Postgraduate medicine.

Inpatient Management of Eating Disorders in Type 1 Diabetes

C. Parkin, J. Jahraus, O. Bermudez, 2009, Diabetes Spectrum.

Impact of Human Factors Testing on Medical Device Design: Validation of an Automated CGM Sensor Applicator

Robert North, Christopher G Parkin, Christine Pospisil, 2019, Journal of diabetes science and technology.

Effective Use of Paired Testing in Type 2 Diabetes

Christopher G. Parkin, W. Polonsky, D. Hinnen, 2009, The Diabetes educator.

ROAD MAP FOR THE PREVENTION AND TREATMENT OF TYPE 2 DIABETES

H. Lebovitz, L. Blonde, P. Jellinger, 2006 .

The impact of blood glucose monitoring on depression and distress in insulin-naïve patients with type 2 diabetes

W. Polonsky, C. Parkin, Z. Jelsovsky, 2011, Current medical research and opinion.

Clinical performance of three bolus calculators in subjects with type 1 diabetes mellitus: a head-to-head-to-head comparison.

Guido Freckmann, Stefan Pleus, Cornelia Haug, 2010, Diabetes technology & therapeutics.

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

J. McGill, I. Hirsch, G. Grunberger, 2023, Diabetes technology & therapeutics.

Performance Variability of Seven Commonly Used Self-Monitoring of Blood Glucose Systems: Clinical Considerations for Patients and Providers

Christopher G Parkin, R. Brazg, C. Parkin, 2013, Journal of diabetes science and technology.

On the Bus or Under the Bus? Is the Current Healthcare System is Endangering Elderly Diabetes Patients

C. Parkin, Larry Ellingson, 2015 .

Primary care physicians identify and act upon glycemic abnormalities found in structured, episodic blood glucose monitoring data from non-insulin-treated type 2 diabetes.

Christopher G Parkin, W. Polonsky, C. Parkin, 2009, Diabetes technology & therapeutics.

Use of Structured Self-Monitoring of Blood Glucose Improves Glycemic Control in Real-World Clinical Practice: Findings from a Multinational and Retrospectively Controlled Trial

T. Tankova, N. Lalic, C. Parkin, 2013, Journal of diabetes science and technology.

Hypoglycemia in Insulin-Treated Diabetes: A Case for Increased Vigilance

C. Parkin, J. Unger, 2011, Postgraduate medicine.

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement From the American Diabetes Association and the European Association for the Study of Diabetes

J. Davidson, C. Parkin, 2007, Diabetes Care.

G6 continuous glucose monitoring system feature use and its associations with glycaemia in Europe

J. Layne, C. Parkin, G. Acciaroli, 2023, Diabetic medicine : a journal of the British Diabetic Association.

Penny Wise and Pound Foolish: Will Shortsighted Cost Reduction Measures Compromise Patient Access to Promising Self-Monitoring of Blood Glucose Technology >

C. Parkin, 2013, Journal of diabetes science and technology.

Integrating Chronic Care into Family Practice: Blending the Paradigms

C. Parkin, David L. Tetrick, 2013, Clinical Diabetes.

Value and utility of structured self-monitoring of blood glucose in real world clinical practice: findings from a multinational observational study.

T. Tankova, N. Lalic, C. Parkin, 2012, Diabetes technology & therapeutics.

Use of an Automated Decision Support Tool Optimizes Clinicians’ Ability to Interpret and Appropriately Respond to Structured Self-Monitoring of Blood Glucose Data

Christopher G. Parkin, Oliver Schnell, H. Rodbard, 2012, Diabetes Care.

Effective Use of Structured Self-Management of Blood Glucose in Type 2 Diabetes: Lessons From the STeP Study

Christopher G. Parkin, D. Hinnen, C. Parkin, 2011, Clinical Diabetes.

A Single-Center, Open, Comparative Study of the Effect of Using Self-Monitoring of Blood Glucose to Guide Therapy on Preclinical Atherosclerotic Markers in Type 2 Diabetic Subjects

V. Mohan, S. Poongothai, R. Ravikumar, 2010, Journal of diabetes science and technology.

Individuals With Type 2 Diabetes Treated With Oral Medications and / or Insulin Treatment With Novel Galactomannan Derivative Reduces 2-Hour Postprandial Glucose Excursions in

C. Parkin, S. Chaidarun, Laura E. Trask, 2014 .

Randomized Studies are Needed to Assess the True Role of Self-Monitoring of Blood Glucose in Noninsulin-Treated Type 2 Diabetes

D. Price, C. Parkin, 2007, Journal of diabetes science and technology.